Characterization of autoantibodies to endothelial cells in systemic sclerosis (SSc): Association with pulmonary fibrosis

Clinical and Experimental Immunology

Volumn 119, Issue 1, 2000, Pages 203-209

  Ihn, H ^a   Sato, S ^a,b   Fujimoto, M ^a   Igarashi, A ^a   Yazawa, N ^a   Kubo, M ^a   Kikuchi, K ^a   Takehara, K ^a,b   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Immunoblotting ELISA; Immunofluorescence

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN M;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC;

EID: 0033983441     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01115.x     Document Type: Article

References (34)

1. 1 Kahaleh MB, Sherer GK, LeRoy EC. Endothelial injury in scleroderma. J Exp Med 1979; 149:1326-35.
2. 2 Springer TA. Adhesion receptors of the immune system. Nature 1990; 346:425-34.
3. 3 Rudnicka L, Majewski S, Blaszczyk M, Skiendzielewska A, Makiela B, Skopinska M, Jablonska S. Adhesion of peripheral blood mononuclear cells to vascular endothelium in patients with systemic sclerosis (scleroderma). Arthritis Rheum 1992; 35:771-5.
4. 4 Cines DB, Lyss AP, Reeher LM, Bina M, DeHoratius RJ. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest 1984; 73:611-25.
5. 5 Lindqvist KJ, Osterland CK. Human antibodies to vascular endothelium. Clin Exp Immunol 1971; 9:753-60.
6. 6 Tan EN, Pearson CM. Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum 1972; 15:23-8.
7. 7 Shingu M, Huri ER. Sera from patients with systemic lupus erythematosus reactive with human endothelial cells. J Rheumatol 1981; 8:581-6.
8. 8 Hashemi S, Smith CD, Izaguirre CA. Anti-endothelial cell antibodies: detection and characterization using a cellular enzyme-linked immunosorbent assay. J Lab Clin Med 1987; 109:434-40.
9. 9 Leung DYM, Geha RS, Newburger JW, Burns J, Fiers W, Lapierre LA, Pober JS. Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome. J Exp Med 1986; 164:1958-72.
10. 10 Brasile L, Kremer JM, Clarke J. Identification of autoantibodies to vascular endothelial cell-specific antigens in patients with systemic vasculitis. Am J Med 1989; 87:74-80.
11. 11 Tanaka Y, Tsukada N, Koh CK, Yanagisawa N. Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis. J Neuroimmunol 1987; 17:49-59.
12. 12 Ferraro G, Meroni PL, Tincani A et al. Anti-endothelial cell antibodies in patients with Wegener's granulomatosis and micropolyarteritis. Clin Exp Immunol 1990; 79:47-53.
13. 13 Sima D, Thiele B, Turowski A, Wilke K, Hiepe F, Volk D, Sonnichsen N. Anti-endothelial antibodies in Takayasu arteritis. Arthritis Rheum 1994; 37:441-2.
14. 14 Van den Zee JM, Siegert CEH, De Vreede TA, Daha MR, Breedveld FC. Characterization of anti-endothelial cell antibodies in systemic lupus erythematosus (SLE). Clin Exp Immunol 1991; 84:238-44.
15. 15 LeRoy EC, Krieg T, Black C, Medger TA Jr, Fleischmajer R, Rowell N, Jablonska S, Wollheim F. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 1988; 15:202-5.
16. 16 Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
17. 17 Ihn H, Sato S, Fujimoto M, Kikuchi K, Igarashi A, Soma Y, Tamaki K, Takehara K. Measurement of anticardiolipin antibodies by ELISA using β2-glycoprotein-1 in systemic sclerosis. Clin Exp Immunol 1996; 105:475-9.
18. 18 Sato S, Ihn H, Kikuchi K, Takehara K. Antihistone antibodies in systemic sclerosis - association with pulmonary fibrosis. Arthritis Rheum 1994; 37:391-4.
19. 19 Savage COS, Pottinger BE, Gaskin G, Lockwood CM, Pusey CD, Pearson JD. Vascular damage in Wegener's granulomatosis and microscopic polyarthritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 1991; 85:14-9.
20. 20 Rattner JB, Martin L, Waisman DM, Johnstone SA, Fritzler MJ. Autoantibodies to the centrosome (centriole) react with determinants present in the glycolytic enzyme enolase. J Immunol 1991; 146:2341-4.
21. 21 Takehara K, Moroi Y, Nakabayashi Y, Ishibashi Y. Antinuclear antibodies in localized scleroderma. Arthritis Rheum 1983; 26:612-6.
22. 22 Tan EN, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C. Diversity of antinuclear antibodies in progressive systemic sclerosis. Arthritis Rheum 1980; 23:617-25.
23. 23 Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease - an apparently distinct rheumatic syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52:148-59.
24. 24 Lazaro MA, Maldonado CJA, Catoggio LJ, Babini SM, Messina OD, Morteo OG. Clinical and serological characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity? Medicine 1989; 68:58-65.
25. 25 Igarashi A, Takehara K, Soma Y, Kikuchi K, Ishibashi Y. Clinical significance of antinuclear antibodies in Japanese patients with systemic sclerosis. Dermatologica 1990; 180:136-40.
26. 26 Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 1988; 31:196-203.
27. 27 Rosenbaum J, Pottinger BE, Woo P, Black CM, Loizou S, Byron MA, Pearson JD. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue disease. Clin Exp Immunol 1988; 72:450-6.
28. 28 Hill MB, Phipps JL, Milford-Ward A, Graves M, Hughes P. Further characterization of anti-endothelial cell antibodies in systemic lupus erythematosus by controlled immunoblotting. Br J Rheumatol 1996; 35:1231-8.
29. 29 Hill MB, Phipps JL, Cartwright RJ, Milford-Ward A, Greaves M, Hughes P. Antibodies to membranes of endothelial cells and fibroblasts in scleroderma. Clin Exp Immunol 1996; 106:491-7.
30. 30 Carvalho D, Savage COS, Black CM, Pearson JD. IgG antiendothelial cell autoantibodies from scleroderma patients induce leukocyte adhesion to human vascular endothelial cells in vitro. J Clin Invest 1996; 97:111-9.
31. 31 Del Papa N, Guidali L, Sironi M et al. Anti-endothelial cell IgG antibodies from patients with Wegener's granulomatosis bind to human endothelial cells in vitro and induce adhesion molecule expression and cytokine secretion. Arthritis Rheum 1996; 39:758-66.
32. 32 Ihn H, Sato S, Fujimoto M, Kikuchi K, Kadono T, Tamaki K, Takehara K. Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines. Br J Rheumatol 1997; 36:1270-5.
33. 33 Majewski S, Hunzelmann N, Johnson JP, Jung C, Mauch C, Ziegler-Heitbroch HWL, Riethmuller G, Kreig T. Expression of intercellular adhesion molecule-1 (ICAM-1) in the skin of patients with systemic scleroderma. J Invest Dermatol 1991; 97:667-71.
34. 34 Jones SM, Mathew CM, Dixey J, Lovell CR, McHuge NJ. VCAM-1 expression on endothelium in lesions from cutaneous lupus erythematosus is increased compared with systemic and localized scleroderma. Br J Dermatol 1996; 135:678-86.